Axogen, Inc.
AXGN- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000805928
In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 4 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Axogen, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 134 | 1 | 119 | −14 |
| Shares | 31.9M | 10.0K | 32.1M | +256.7K (+0.8%) |
| Value | $290.9M | $91.3K | $160.5M | −$130.3M (−44.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Axogen, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Keeley-Teton Advisors, LLC | 36,000 | $180.0K | 0.03% |
| Qube Research & Technologies Ltd | 24,115 | $120.6K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 22,662 | $113.3K | 0.01% |
| Creative Planning | 18,908 | $94.5K | 0.00% |
| Cetera Advisors LLC | 18,399 | $92.0K | 0.00% |
| Centiva Capital, LP | 17,502 | $87.5K | 0.00% |
| Sherbrooke Park Advisers LLC | 16,513 | $82.6K | 0.03% |
| Point72 Middle East FZE | 16,345 | $81.7K | 0.00% |
| Eagle Asset Management Inc | 12,567 | $62.8K | 0.00% |
| UBS Asset Management Americas Inc | 10,538 | $52.7K | 0.00% |
| SG Americas Securities, LLC | 10,157 | $51.0K | 0.00% |
Sold out (25)
Institutions that held Axogen, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (1)
Institutions that held Axogen, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BerganKDV Wealth Management, LLC | 10,000 | $91.3K |